Torrent Pharmaceuticals

CompanyIndia

Torrent Pharmaceuticals develops one asset. Mostly small molecule acting on SLC5A2 and ABCC8; based in India.

1
Asset
Furthest stage: Not known; 15
Trials: 0
Signals

Pipeline

1

Dapagliflozin/Glimepiride/Metformin
Combines increased urinary glucose excretion, stimulated insulin secretion, and reduced hepatic glucose production to improve glycemic control.
Stage not known, Small molecule, SLC5A2, ABCC8

Full company profiles: pipeline, trials, funding and people.

In the full profile

Evidence behind the mechanisms2
Trials15
Signals1
Similar companies6

Papers

Real-World Effectiveness and Safety of Dapagliflozin/Glimepiride/Metformin Fixed-Dose Combinations (FDC) in Indian Adults with Type 2 Diabetes Mellitus (T2DM): Insights from BENEFACTOR Study
ADA Scientific Sessions 2026 abstract, 6 Jun 2026